Annual report [Section 13 and 15(d), not S-K Item 405]

Accrued and Other Current Liabilities

v3.26.1
Accrued and Other Current Liabilities
12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities

5. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following:

 

 

 

December 31,

 

 

 

2025

 

 

2024

 

Compensation expense

 

$

9,716

 

 

$

8,315

 

Clinical trial research and development services

 

 

5,335

 

 

 

1,236

 

Manufacturing and other research and development services

 

 

3,774

 

 

 

2,255

 

General and administrative services

 

 

393

 

 

 

342

 

Other

 

 

80

 

 

 

40

 

 

 

$

19,298

 

 

$

12,188